Le Lézard
Classified in: Health
Subjects: LGB, DEI

Fenway Health clinicians and researchers author first edition of Transgender and Gender Diverse Health Care: The Fenway Guide published by McGraw Hill Professional


BOSTON, Oct. 6, 2021 /PRNewswire-PRWeb/ -- Fenway Health announces the release of the first case-based textbook to address the comprehensive health care needs of transgender and gender diverse adults. Co-edited by Drs. Alex S. Keuroghlian, Jennifer Potter, and Sari L. Reisner of The Fenway Institute at Fenway Health, this sentinel resource was published by McGraw Hill Professional.

Transgender and Gender Diverse Health Care: The Fenway Guide offers a roadmap for clinicians who seek to provide culturally responsive care that meets the primary, preventive, and specialty health care needs of transgender and gender diverse adult patients. Authored by Fenway Health clinicians, researchers, staff members and other national experts, the Guide highlights best practices in care from the perspectives of multiple stakeholders.

"Demand for state-of-the-art health care services for transgender and gender diverse people is rapidly increasing," said Dr. Alex S. Keuroghlian, Director of the National LGBTQIA+ Health Education Center at The Fenway Institute, Associate Professor of Psychiatry at Harvard Medical School, and Director of the Massachusetts General Hospital Psychiatry Gender Identity Program. "This textbook is an invaluable resource to all clinicians who care for transgender and gender diverse adults."

"Medical providers have a responsibility to be familiar with the most up-to-date scientific and clinical information, and they can find all of that information and more in this guide, which highlights key aspects of gender identity emergence across the lifespan and provides much-needed guidance on both hormonal and surgical gender affirmation," said Dr. Jennifer Potter, Co-Chair of The Fenway Institute at Fenway Health, Professor of Medicine at Harvard Medical School, and co-editor of The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health, published in 2015.

"We have long known that transgender and gender diverse adults experience health care disparities largely rooted in stigma, including acts of discrimination that take place in health care settings," said Sari L. Reisner, Sc.D, Director of Transgender Health Research at The Fenway Institute, Assistant Professor of Medicine at Harvard Medical School,and Director of Transgender Research at Brigham and Women's Hospital based in the Division of Endocrinology, Diabetes and Hypertension. "Our textbook applies a health-equity model of care and provides guidance for clinicians when addressing health needs of transgender and gender diverse communities."

Transgender and Gender Diverse Health Care: The Fenway Guide features essential information that includes but is not limited to the following topics:

Transgender and Gender Diverse Health Care: The Fenway Guide will be distributed by all major general and medical booksellers. It is available for purchase at McGraw Hill and Amazon.com.

About Fenway Health
Founded in 1971, Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish.

Media Contact

Chris Viveiros, Fenway Health, 6179276342, [email protected]

Twitter

 

 

SOURCE Fenway Health


These press releases may also interest you

at 16:32
The wishes that Make-A-Wish grants wouldn't be possible without the support of countless "WishMakers" such as donors, volunteers, corporate partners, community advocates and more. "WishMakers" ? a term for anyone who steps up to take action...

at 16:30
Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced a new appointment to the Canadian Centre on Substance Use and Addiction (CCSA) Board of Directors. Scott Elliott is appointed as...

at 16:28
The Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions, a leading provider of innovative healthcare technologies, in their upcoming biosensor validation study called VIBRANT. PMD Solutions will generously...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...

at 16:20
AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that its Board of Directors has unanimously approved plans to initiate a rights offering. The...



News published on and distributed by: